Protein synthesis inhibiting clindamycin improves outcome in a mouse model of staphylococcus aureus sepsis compared with the cell wall active ceftriaxone

Critical Care Medicine

Volumn 30, Issue 7, 2002, Pages 1560-1564

  Azeh, Ivo ^a   Gerber, Joachim ^a   Wellmer, Andreas ^a   Wellhausen, Malte ^a   Koenig, Brigitte ^b   Eiffert, Helmut ^a   Nau, Roland ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Ceftriaxone; Clindamycin; Mortality; Peritonitis; Sepsis; Staphylococcus aureus

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CLINDAMYCIN; CYTOKINE; ENTEROTOXIN; OXACILLIN; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; LETHALITY; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURVIVAL;

EID: 0036317828     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200207000-00027     Document Type: Article

References (19)

1. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of Gram-negative sepsis
2. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure
3. Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli
4. Effects of antibiotic class on macrophage inflammatory response to Streptococcus pneumoniae
5. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: Quantitative measurements and biological reactivities
6. Antibodies to Staphylococcus aureus peptidoglycan and lipoteichoicacid in staphylococcal infections
7. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates
8. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to β-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin
9. Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes
10. Spatial memory and learning deficits after experimental pneumococcal meningitis in mice
11. A simple technique for evaluation of vitality loss in aging mice, by testing their muscular coordination and vigor
12. The Eagle effect revisited: Efficacy of clindamycin, erythromycin and penicillin in the treatment of streptococcal myositis
13. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis
14. The activity of isoxazolyl penicillins in experimental staphylococcal infection
15. Choosing an antibiotic on the basis of pharmacodynamics
16. Synthesis and antimicrobial activity of clindamycin analogues: Pirlimycin, a potent antibacterial agent
17. Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis
18. Antibiotic treatment of experimental pneumonic plague in mice
19. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations